Iambic Therapeutics Charting new paths to superior medicines

Iambic Therapeutics Marks a Key Milestone in Advancing Cancer Treatment: IND Submission for IAM1363, a Selective, Brain-Penetrant HER2 Inhibitor

News & Media Iambic Therapeutics

Frontiers Entering First-in-Human Clinical Study With a Single-Strain Live Biotherapeutic Product: Input and Feedback Gained From the EMA and the FDA

Portfolio - Illumina Ventures

Iambic Therapeutics

Iambic Therapeutics

Get Latest Industry, Featured News & Updates

The hospital exemption pathway for the approval of advanced therapy medicinal products: an underused opportunity? The case of the CAR-T ARI-0001

Pipeline Iambic Therapeutics

Get Latest Industry, Featured News & Updates

Iambic Therapeutics Charting new paths to superior medicines